QuidelOrtho (QDEL) Cost of Revenue (2021 - 2024)

QuidelOrtho (QDEL) has 4 years of Cost of Revenue data on file, last reported at $378.9 million in Q1 2024.

• For the quarter ending Q1 2024, Cost of Revenue fell 4.68% year-over-year to $378.9 million; the trailing twelve-month figure through Mar 2024 stood at $2.6 billion (up 9.95% YoY), and the FY2024 full-year result was $51.8 million, down 96.55% from the prior year.
• Cost of Revenue declined to $378.9 million in Q1 2024, from $1.5 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $1.5 billion in Q4 2023 to a low of $134.4 million in Q4 2021.
• A 4-year average of $539.0 million and a median of $376.1 million in 2022 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue soared 179.99% in 2022 and retreated 4.68% in 2024, its largest moves.
• Tracing QDEL's Cost of Revenue over 4 years: stood at $134.4 million in 2021, then jumped by 179.99% to $376.3 million in 2022, then soared by 296.68% to $1.5 billion in 2023, then plunged by 74.62% to $378.9 million in 2024.
• Business Quant data shows QDEL's Cost of Revenue at $378.9 million in Q1 2024, $1.5 billion in Q4 2023, and $375.9 million in Q4 2023.